Showing results (461-470 of 573) with videos related to
Sort By:
Pageof 58
Cancer Chemotherapy and Pharmacology|March 26, 2016
Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancersMuhammad R Khawaja, Alpa M Nick, Vinu Madhusudanannair, et al.British Journal of Cancer|March 20, 2018
Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trialMichael L Maitland, Sarina Piha-Paul, Gerald Falchook, et al.Cancer Science|November 29, 2019
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohortsYung-Jue Bang, Wu-Chou Su, Martin Schuler, et al.Bioorganic Chemistry|February 24, 2021
Synthesis and biological evaluation of pentacyclic triterpenoid derivatives as potential novel antibacterial agentsPanpan Wu, Borong Tu, Jinfeng Liang, et al.Oncotarget|May 8, 2018
Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutationsNeeta Somaiah, Hannah C Beird, Andrea Barbo, et al.RSC Chemical Biology|January 5, 2024
Design, synthesis and modelling of photoreactive chemical probes for investigating target engagement of plasmepsin IX and X in Plasmodium falciparumMonika Lisauskaitė, Gemma L Nixon, Christopher M Woodley, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With ImmunotherapyChristine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.Oncotarget|October 4, 2018
Outcome analysis of Phase I trial patients with metastatic KRAS and/or TP53 mutant non-small cell lung cancerYudong Wang, Zhijie Wang, Sarina Piha-Paul, et al.Journal for Immunotherapy of Cancer|July 4, 2023
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trialMehmet Altan, Yan Wang, Juhee Song, et al.Clinical and Translational Radiation Oncology|August 27, 2024
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer centerAlan J Sosa, Michael K Rooney, Howard D Thames, et al.Pageof 58